NSC |
Compound |
Enrichment |
Correlation |
NSC 677261 |
Null |
0.00374367388796147 |
-0.068941603 |
NSC 679287 |
Null |
0.00374367388796147 |
-0.16797335 |
NSC 694002 |
2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester |
0.00374367388796147 |
-0.2719092 |
NSC 724058 |
3-[(N,N-Dimethylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8 ,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.00374367388796147 |
-0.13728604 |
NSC 735846 |
Null |
0.00374367388796147 |
-0.034786207 |
NSC 747556 |
6-(4'-Hydroxy-2'-methylphenyl)-2-benzenesulfonamide-4,5-dihydropyridazine-3(2H)-one |
0.00374367388796147 |
-0.22681505 |
NSC 754240 |
2,9-dimethoxy-6-(2-(piperidin-1-yl)ethoxy)-11H-indeno[1,2-c]quinolin-11-one |
0.00374367388796147 |
-0.20853755 |
NSC 628917 |
3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide |
0.00414350254426684 |
-0.22841868 |
NSC 639505 |
Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride |
0.00414350254426684 |
-0.26627566 |
NSC 639511 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride |
0.00414350254426684 |
-0.38669655 |